Supplemental Figure Legends from STING Promotes the Growth of Tumors Characterized by Low Antigenicity Via IDO Activation

Henrique Lemos,Eslam Mohamed,Lei Huang,Rong Ou,Gabriela Pacholczyk,Ali S. Arbab,David Munn,Andrew L. Mellor

DOI: https://doi.org/10.1158/0008-5472.22411824

2023-01-01

Abstract:Legends for Supplemental Figures S1-S3.

What problem does this paper attempt to address?

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Supplemental Figure Legends from STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Heng Yang,Takahiro Yamazaki,Federico Pietrocola,Heng Zhou,Laurence Zitvogel,Yuting Ma,Guido Kroemer

DOI: https://doi.org/10.1158/0008-5472.22404671

2023-01-01

Abstract:Supplemental Figure Legends. Supplemental Figure Legends
Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Xiao Lin,Dae Joong Kim,Clayton L. Davis,James V. McCann,James M. Dunleavey,Alissa K. Vanderlinden,Nuo Xu,Samantha G. Pattenden,Stephen V. Frye,Xin Xu,Mark Onaitis,Elizabeth Monaghan-Benson,Keith Burridge,Andrew C. Dudley

DOI: https://doi.org/10.1158/0008-5472.22406702

2023-01-01

Abstract:Legends for Supplemental Figures S1-S7.
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplementary Figure Legends from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling

Huafeng Zhang,Ke Tang,Yi Zhang,Ruihua Ma,Jingwei Ma,Yong Li,Shunqun Luo,Xiaoyu Liang,Tiantian Ji,Zhichao Gu,Jinzhi Lu,Wei He,Xuetao Cao,Yonghong Wan,Bo Huang

DOI: https://doi.org/10.1158/2326-6066.22538213

2023-01-01

Abstract:Supplementary Figure Legends
Supplemental Figure Legends from Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Enxiu Wang,Liang-Chuan Wang,Ching-Yi Tsai,Vijay Bhoj,Zack Gershenson,Edmund K. Moon,Kheng Newick,Jing Sun,Albert Lo,Timothy Baradet,Michael D. Feldman,David M. Barrett,Ellen Puré,Steven Μ. Albelda,Michael C. Milone

DOI: https://doi.org/10.1158/2326-6066.22538600.v1

2023-01-01

Abstract:Figure legends for supplemental data.
Supplementary Figure Legends from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

Weifang Ling,Jimin Zhang,Zengrong Yuan,Guangwen Ren,Liying Zhang,Xiaodong Chen,Arnold B. Rabson,Arthur I. Roberts,Ying Wang,Yufang Shi

DOI: https://doi.org/10.1158/0008-5472.22400904

2023-01-01

Abstract:PDF file - 97KB
Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Xiaohong Wu,Govind Ragupathi,Katherine S. Panageas,Feng Hong,Philip O. Livingston

DOI: https://doi.org/10.1158/1078-0432.22446662

2023-01-01

Abstract:Legend for supplementary figures - PDF file 62K, Supplementary Figure Legend
Supplementary Legends from Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers

Hongyi Zhang,Longchao Liu,Jian Zhang,Jiahui Chen,Jianfeng Ye,Sachet Shukla,Jian Qiao,Xiaowei Zhan,Hao Chen,Catherine J. Wu,Yang-Xin Fu,Bo Li

DOI: https://doi.org/10.1158/1078-0432.22479561.v1

2023-01-01

Abstract:Legends for supplementary figures, tables and datasets.
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.
Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Jongchan Kim,Ashley N. Siverly,Dahu Chen,Min Wang,Yuan,Yumeng Wang,Hyemin Lee,Jinsong Zhang,William J. Muller,Han Liu,Boyi Gan,Xianbin Yang,Yeneng Sun,M. James You,Ma Li

DOI: https://doi.org/10.1158/0008-5472.22413063.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S11
Supplemental Figure Legend from LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases

Guilin Qiao,Jianzhong Qin,Nicholas Kunda,Jed F. Calata,Dolores L. Mahmud,Peter Gann,Yang-Xin Fu,Steven A. Rosenberg,Bellur S. Prabhakar,Ajay V. Maker

DOI: https://doi.org/10.1158/0008-5472.22415712.v1

2023-01-01

Abstract:Supplemental Figure Legend from LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases
Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Huafeng Wei,Hao Wang,Bing Lu,Bohua Li,Sheng Hou,Weizhu Qian,Kexing Fan,Jianxin Dai,Jian Zhao,Yajun Guo

DOI: https://doi.org/10.1158/0008-5472.22375065.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Supplemental Figures and Tables Legends from Notch1 Mutations Are Drivers of Oral Tumorigenesis

Evgeny Izumchenko,Kening Sun,Siân Jones,Mariana Brait,Nishant Agrawal,Wayne M. Koch,Christine L. McCord,David R. Riley,Samuel V. Angiuoli,Victor E. Velculescu,Wei‐Wen Jiang,David Sidransky

DOI: https://doi.org/10.1158/1940-6207.22526591

2023-01-01

Abstract:Supplemental Figures and Tables legends
Supplemental Figure Legends from Obesity Contributes to Ovarian Cancer Metastatic Success Through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages

Yueying Liu,Matthew N. Metzinger,Kyle A. Lewellen,Stephanie N. Cripps,Kyle D. Carey,Elizabeth I. Harper,Zonggao Shi,Laura Tarwater,Annie Grisoli,Eric Lee,Ania Slusarz,Jing Yang,Elizabeth A. Loughran,Kaitlyn Conley,Jeff J. Johnson,Yuliya Klymenko,Lana Bruney,Zhong Liang,Norman J. Dovichi,Bentley Cheatham,W. Matthew Leevy,M. Sharon Stack

DOI: https://doi.org/10.1158/0008-5472.22407659.v1

2023-01-01

Abstract:Legends for Supplemental Figures S1-S4
Supplemental Figure Legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Dong‐Tsamn Lin,Lei,Yonghao Liu,Yinsheng Zhang,Bo Hu,Guirong Bao,Songliu Yuan,Jin Zou,Chunliang Liu,Miao Yu,Dedy Sandikin,Yan Wu,Lei Zhao,Yu X,Haiyan Liu

DOI: https://doi.org/10.1158/0008-5472.22408238

2023-01-01

Abstract:Supplemental figure legends
Supplemental Figure Legends from Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma

Jenifer B. Gifford,Wei Huang,Ann E. Zeleniak,Antreas Hindoyan,Hong Wu,Timothy R. Donahue,Reginald Hill

DOI: https://doi.org/10.1158/1535-7163.22508517

2023-01-01

Abstract:Figure legends for the supplemental table and each of the supplemental figures.
Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Li Liu,Xue Bai,Jian Wang,Xiaonan Tang,Dehua Wu,Shasha Du,Xiu-Ju Du,Yao-Wei Zhang,Hai‐Liang Zhu,Yuan Fang,Zhimou Guo,Qiandong Zeng,Xuejun Guo,Zhu Li,Zhong‐Yi Dong

DOI: https://doi.org/10.1158/1078-0432.22471917.v1

2023-01-01

Abstract:Supplementary figure legends
Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Yan Kong,Lu Si,Yiqian Li,Xiaowen Wu,Xiaowei Xu,Jie Dai,Huan Tang,Meng Ma,Zhihong Chi,Xinan Sheng,Chuanliang Cui,Jun Guo

DOI: https://doi.org/10.1158/1078-0432.22461800.v1

2023-01-01

Abstract:Figure legends for Supplementary Figure S1 and Figure S2

Supplemental Figure Legends from STING Promotes the Growth of Tumors Characterized by Low Antigenicity Via IDO Activation

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplemental Figure Legends from STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells

Supplemental Figure Legends from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling

Supplemental Figure Legends from Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Supplementary Figure Legends from Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplementary Legends from Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Supplemental Figure Legend from LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases

Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplemental Figures and Tables Legends from Notch1 Mutations Are Drivers of Oral Tumorigenesis

Supplemental Figure Legends from Obesity Contributes to Ovarian Cancer Metastatic Success Through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages

Supplemental Figure Legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Supplemental Figure Legends from Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma

Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors